Validation of the Classification for Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases
1 other identifier
observational
116
1 country
1
Brief Summary
The aim of this study is to validate a proposed classification system regarding overall survival as well as a comparison with patients with liver metastases and extrahepatic metastasis of colorectal cancer. The study also aims to identify the proportion of patients in each group, the proportion of patients converted from 4c to 4b and to compare survival to the patients only treated with chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 29, 2026
CompletedFirst Posted
Study publicly available on registry
May 6, 2026
CompletedMay 6, 2026
April 1, 2026
4.4 years
April 29, 2026
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall survival
3 years
Interventions
Removal or destruction of liver tumors
Eligibility Criteria
All patients with colorectal liver metastases assessed at multidisciplinary team conferences in Linköping University Hospital 2021-11-01 -- 2022-12-31
You may qualify if:
- Colorectal liver metastasis.
- Discussed at a multidisciplinary tumor board
You may not qualify if:
- Age less than 18 years.
- Previous cancer in the gastrointestinal tract
- Ongoing oncological treatment for cancers other than gastrointestinal cancers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Linkoepinglead
- Linkoeping Universitycollaborator
Study Sites (1)
Linköping University Hospital
Linköping, Sweden
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 29, 2026
First Posted
May 6, 2026
Study Start
November 1, 2021
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
May 6, 2026
Record last verified: 2026-04